PALMIERI, Giuseppe
 Distribuzione geografica
Continente #
NA - Nord America 17.093
AS - Asia 10.334
SA - Sud America 6.421
EU - Europa 4.623
AF - Africa 398
Continente sconosciuto - Info sul continente non disponibili 41
OC - Oceania 39
Totale 38.949
Nazione #
US - Stati Uniti d'America 16.700
BR - Brasile 5.726
SG - Singapore 4.928
CN - Cina 2.254
UA - Ucraina 1.329
HK - Hong Kong 960
VN - Vietnam 828
DE - Germania 617
FR - Francia 593
IT - Italia 537
SE - Svezia 423
FI - Finlandia 308
GB - Regno Unito 213
AR - Argentina 204
TR - Turchia 182
CA - Canada 148
IN - India 147
MX - Messico 146
BD - Bangladesh 140
IQ - Iraq 134
EC - Ecuador 131
RU - Federazione Russa 125
ZA - Sudafrica 108
VE - Venezuela 94
MA - Marocco 93
JP - Giappone 82
CO - Colombia 80
UZ - Uzbekistan 79
PL - Polonia 73
PK - Pakistan 69
KR - Corea 68
AT - Austria 66
NL - Olanda 55
PY - Paraguay 50
ES - Italia 49
CL - Cile 48
JO - Giordania 48
KE - Kenya 48
TN - Tunisia 45
ID - Indonesia 44
AZ - Azerbaigian 42
BE - Belgio 39
AE - Emirati Arabi Uniti 36
AU - Australia 36
UY - Uruguay 35
NP - Nepal 31
PE - Perù 29
RO - Romania 28
EU - Europa 27
KZ - Kazakistan 27
AL - Albania 26
LT - Lituania 25
OM - Oman 25
DZ - Algeria 24
CZ - Repubblica Ceca 23
LB - Libano 22
JM - Giamaica 21
BO - Bolivia 20
EG - Egitto 20
SA - Arabia Saudita 20
KG - Kirghizistan 19
IL - Israele 18
DO - Repubblica Dominicana 17
HN - Honduras 17
IR - Iran 16
RS - Serbia 16
BH - Bahrain 15
PH - Filippine 15
SN - Senegal 15
PA - Panama 13
SY - Repubblica araba siriana 12
CI - Costa d'Avorio 11
GE - Georgia 11
PS - Palestinian Territory 11
BY - Bielorussia 10
IE - Irlanda 10
AM - Armenia 9
BG - Bulgaria 9
CR - Costa Rica 9
CH - Svizzera 8
NI - Nicaragua 8
XK - ???statistics.table.value.countryCode.XK??? 8
ET - Etiopia 7
MN - Mongolia 7
A2 - ???statistics.table.value.countryCode.A2??? 6
KW - Kuwait 6
MY - Malesia 6
NG - Nigeria 6
TT - Trinidad e Tobago 6
AO - Angola 5
BN - Brunei Darussalam 5
GR - Grecia 5
LK - Sri Lanka 5
MD - Moldavia 5
BA - Bosnia-Erzegovina 4
DK - Danimarca 4
HU - Ungheria 4
PT - Portogallo 4
GA - Gabon 3
GT - Guatemala 3
Totale 38.896
Città #
Dallas 6.112
Singapore 2.713
Chandler 2.350
San Jose 1.207
Hong Kong 948
Ashburn 770
Princeton 768
Jacksonville 661
Beijing 422
São Paulo 389
Lauterbourg 373
Ho Chi Minh City 303
Wilmington 286
Dearborn 276
Nanjing 262
Shanghai 251
Hanoi 195
Belo Horizonte 172
Santa Clara 165
New York 162
Rio de Janeiro 158
Ann Arbor 150
Los Angeles 149
Helsinki 141
Boardman 125
Brasília 113
Nanchang 112
Sassari 107
Orem 86
Porto Alegre 82
Curitiba 81
Campinas 80
Frankfurt am Main 79
Tokyo 79
Columbus 74
The Dalles 74
Tianjin 72
Council Bluffs 68
Seoul 67
Tashkent 67
Nuremberg 65
Shenyang 61
Warsaw 61
San Francisco 58
Norwalk 55
Changsha 54
Guarulhos 54
Johannesburg 54
Hebei 53
Baghdad 52
Jiaxing 51
Da Nang 48
Toronto 48
Amman 47
Goiânia 47
Osasco 44
Chennai 42
Munich 42
Nairobi 42
Montreal 41
Ribeirão Preto 41
Salvador 41
Santo André 40
Brussels 39
Dhaka 39
Guayaquil 39
Istanbul 39
Brooklyn 38
Fortaleza 38
Buffalo 37
Manaus 36
Mexico City 36
Mountain View 36
Falls Church 35
Haiphong 35
Quito 35
Stockholm 35
Vienna 35
Woodbridge 35
Betim 34
Amsterdam 33
Baku 33
Caxias do Sul 33
Chicago 33
Joinville 33
Sorocaba 33
São Bernardo do Campo 33
Ankara 32
Atlanta 32
London 32
Recife 32
Cagliari 31
Campo Grande 31
Kunming 31
Juiz de Fora 29
Pelotas 29
Poplar 29
Falkenstein 28
Milan 28
Montevideo 28
Totale 23.134
Nome #
Clinical, Histopathological, Dermoscopic Features, and BRAF, NRAS, and Cell Cycle Genes’ Mutation Status in Cutaneous Melanoma 1.166
A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis 343
KRAS mutations in Non-Small Cell Lung Cancer: translational aspects, current therapies and challenges for future research 305
Allelic Gains And Losses At 10q25-Q26 In Malignancies Of The Uterine Corpus: Demonstration Of Two Distinctive Genetic Alterations 280
EGFR mutation detection in Whole Slide Images of non-small cell lung cancers using a two-stage deep transfer learning approach 260
Aspetti epidemiologici dei tumori maligni dell’ovaio nel Nord Sardegna nel periodo 1992-2001 248
Analysis of fanconi anemia genes in colorectal cancer 205
A Founder Mutation In Sardinian Breast Cancer Families Detected By Identity-By-Descent Method 195
Analysis of the mapk-erk gene pathway in primary and metastatic melanoma cell lines 193
A role of BRCA1 and BRCA2 germline mutations in breast cancer susceptibility within Sardinian population 191
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 187
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 187
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 183
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 178
Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans 177
Breast cancer incidence and mortality in North Sardinia in the period 1992 - 2010 176
A novel candidate gene in human endometrial cancer at chromosome 10q26 173
Deciduoid mesothelioma of the thorax: A comprehensive review of the scientific literature 173
Epidemiology of thyroid cancer in an area of epidemic thyroid goiter 172
CASC2a gene is down-regulated in endometrial cancer 165
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 163
Breast Nodular Fasciitis: A Comprehensive Review 163
A Diagnostic of Acquired Hemophilia Following PD1/PDL1 Inhibitors in Advanced Melanoma: The Experience of Two Patients and a Literature Review 162
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study 162
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1,440 Sardinian patients with lung adenocarcinoma. 158
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 156
Long non-coding RNA CASC2 in human cancer 155
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 153
Phenotype characterization of human melanoma cells resistant to dabrafenib 151
Disease progression and overall survival in sardinian patients with colorectal cancer according to the kras mutational status 149
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 149
Breast cancer incidence and mortality in North Sardinia in the period 1992–2010 145
Female Adnexal Tumors of Probable Wolffian Origin (FATWO): A Case Series with Next-Generation Sequencing Mutation Analysis 141
Genetic alterations in main candidate genes during melanoma progression 141
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 139
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 137
Presence of Jaagsiekte sheep retrovirus in tissue sections from human bronchioloalveolar carcinoma depends on patients' geographical origin 137
Fanconi genes may contribute to melanoma pathogenesis 136
Colorectal cancer epidemiology in an area with a spontaneous screening program 135
Genetic Instability Markers in Cancer 135
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 135
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma 134
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma 133
Repurposing anticancer drugs for the treatment of idiopathic pulmonary fibrosis and antifibrotic drugs for the treatment of cancer: state of the art 133
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 132
BRAF mutations and dysregulation of the MAP kinase pathway associated to sinonasal mucosal melanomas 131
Mutation analysis of mucosal and cutaneous melanomas during progression 131
Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma - Identification of specific patterns of genetic alteration 131
Cytogenetic assessment of the involvement of a new locus at 9p21 in malignant melanoma 130
Adjuvant therapy of cutaneous melanoma 130
Adjuvant treatment of malignant melanoma: where are we? 130
Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy 130
Impact of COVID-19 outbreak on cancer immunotherapy in Italy: A survey of young oncologists 129
Molecular classification of patients with malignant melanoma for new therapeutic strategies 127
Head and neck cancer epidemiology in North Sardinia, Italy. 126
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 126
KRAS mutational concordance between primary and metastatic colorectal adenocarcinoma 125
Detection of occult melanoma cells in paraffin-embedded histologically negative sentinel lymph nodes using a reverse transcriptase polymerase chain reaction assay 125
Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer 123
Uterine perivascular epithelioid cell neoplasms (PEComas): Report of two cases and literature review 123
X-inactivation patch size in human female tissue confounds the assessment of tumor clonality 122
Antitumoral effect of vanadium compounds in malignant melanoma cell lines 122
Epidemiology of malignant pleural mesothelioma in the province of Sassari (Sardinia, Italy). A population-based report 120
2,2’-dihydroxy-3,3’-dimethoxy-5,5’-dimethyl-6,6’-dibromo-1,1’-biphenyl: preparation, resolution, structure and biological activity 120
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 119
Microsatellite and fish analysis in endometrial cancer: Assessment of specific patterns of genetic and cytogenetic alterations with their clinical correlations 119
Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells 119
Epidemiological aspects of ovarian malignancies in North Sardinia in the period 1992-2001 118
Protein expression changes induced in a malignant melanoma cell line by the curcumin analogue compound D6 118
Immunohistochemistry and biomolecular investigation for the evidence of JSRV-like retrovirus in human bronchiolo-alveolar carcinomas 118
Microsatellite analysis at 10q25-q26 in Sardinian patients with sporadic endometrial carcinoma 117
Actin-binding protein (ABP-280) filamin gene maps telomeric to the color vision locus (R/GCP) and centromeric to G6PD in Xq28. 117
Human gene mutations gene symbol: BRCA2 small insertion in breast cancer 116
The effect of COVID-19 emergency in the management of melanoma in Italy 116
An evaluation of talazoparib plus enzalutamide for the treatment of metastatic castration-resistant prostate cancer 115
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia 114
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predispositions 114
Antiproliferative activity of vanadium compounds: Effects on the major malignant melanoma molecular pathways 114
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: report of two cases with molecular analysis 113
A vision of immuno-oncology: the Siena think tank of the Italian network for tumor biotherapy (NIBIT) foundation 113
Primary dermal melanoma in a patient with a history of multiple malignancies: a case report with molecular characterization 113
Screening for founder mutations in BRCA1/2 tumor susceptibility genes among breast cancer families from North Sardinia 113
Indagini immunoistochimiche e biomolecolari per l’evidenziazione di retrovirus jsrv-correlati, in carcinomi bronchiolo-alveolari dell’uomo 113
3-year treatment with recombinant interferon- as adjuvant therapy of cutaneous malignant melanoma. 111
BRAF and PIK3CA genes are somatically mutated in hepatocellular carcinoma among patients from South Italy 111
A Role ofBRCA1andBRCA2germline mutations in breast cancer susceptibility within Sardinian population 111
Identification of different patterns of genetic alteration (a new minimal LOH region at chromosome 10q25-26 and genomic instability) in Sardinian patients with sporadic endometrial cancer and correlation with clinicopathological parameters 111
Pancreatic cancer burden in North Sardinia, Italy 110
1.5-Mb YAC contig in Xq28 formatted with sequence-tagged sites and including a region unstable in the clones 110
Synchronous interdigitating dendritic cell sarcoma and B-cell small lymphocytic lymphoma in a lymph node 109
Primary melanoma of the lung: A systematic review 109
An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival 109
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 109
Assessment of microsatellite instability in benign nevi, dysplastic nevi, and primary melanomas along with their metastases 108
Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia 108
Overexpression of h-prune in breast cancer is correlated with advanced disease status 107
Epidemiology of ovarian cancer in North Sardinia, Italy, during the period 1992-2010 107
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign naevi, dysplastic naevi, and primary melanomas and their metastases 106
Assessment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 106
Low Levels of Genetic Heterogeneity in Matched Lymph Node Metastases from Patients with Melanoma 106
Totale 15.239
Categoria #
all - tutte 165.467
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 165.467


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021634 0 0 0 0 0 0 0 0 0 439 116 79
2021/20221.591 150 8 7 28 21 35 81 129 144 130 171 687
2022/20234.418 431 204 76 818 370 874 2 493 803 36 187 124
2023/20241.088 260 119 29 36 125 81 26 109 3 19 93 188
2024/202511.568 93 83 657 213 405 510 489 2.503 4.350 1.556 427 282
2025/202616.070 465 5.038 2.153 2.074 1.574 931 2.281 473 690 391 0 0
Totale 39.438